Related references
Note: Only part of the references are listed.Interactions of OP0595, a Novel Triple-Action Diazabicyclooctane, with beta-Lactams against OP0595-Resistant Enterobacteriaceae Mutants
David M. Livermore et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Structural and Kinetic Characterization of Diazabicyclooctanes as Dual Inhibitors of Both Serine-β-Lactamases and Penicillin-Binding Proteins
Andrew M. King et al.
ACS CHEMICAL BIOLOGY (2016)
In Vitro and In Vivo Activities of OP0595, a New Diazabicyclooctane, against CTX-M-15-Positive Escherichia coli and KPC-Positive Klebsiella pneumoniae
Akihiro Morinaka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Boronic Acid Transition State Inhibitors Active against KPC and Other Class A β-Lactamases: Structure-Activity Relationships as a Guide to Inhibitor Design
Laura J. Rojas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Investigations on recyclisation and hydrolysis in avibactam mediated serine beta-lactamase inhibition
Hwanho Choi et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2016)
Restricting the ψ Torsion Angle Has Stereoelectronic Consequences on a Scissile Bond: An Electronic Structure Analysis
Eric R. Strieter et al.
BIOCHEMISTRY (2015)
The Allosteric Site for the Nascent Cell Wall in Penicillin-Binding Protein 2a: An Achilles' Heel of Methicillin-Resistant Staphylococcus aureus
Ivan Acebron et al.
CURRENT MEDICINAL CHEMISTRY (2015)
Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases
Krisztina M. Papp-Wallace et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2015)
Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamases
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'
Akihiro Morinaka et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
The Tipper-Strominger Hypothesis and Triggering of Allostery in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus (MRSA)
Jennifer Fishovitz et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Mind the Gap: Raman Evidence for Rapid Inactivation of CTX-M-9 β-Lactamase Using Mechanism-Based Inhibitors that Bridge the Active Site
Hossein Heidari-Torkabadi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Molecular Basis of Selective Inhibition and Slow Reversibility of Avibactam against Class D Carbapenemases: A Structure-Guided Study of OXA-24 and OXA-48
Sushmita D. Lahiri et al.
ACS CHEMICAL BIOLOGY (2015)
Inhibition of Klebsiella β-Lactamases (SHV-1 and KPC-2) by Avibactam: A Structural Study
Nikhil P. Krishnan et al.
PLOS ONE (2015)
In Vitro Activities of Ceftazidime-Avibactam and Aztreonam-Avibactam against 372 Gram-Negative Bacilli Collected in 2011 and 2012 from 11 Teaching Hospitals in China
Xiaojuan Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Inactivation of TEM-1 by Avibactam (NXL-104): Insights from Quantum Mechanics/Molecular Mechanics Metadynamics Simulations
Jacopo Sgrignani et al.
BIOCHEMISTRY (2014)
Tebipenem, a New Carbapenem Antibiotic, Is a Slow Substrate That Inhibits the β-Lactamase from Mycobacterium tuberculosis
Saugata Hazra et al.
BIOCHEMISTRY (2014)
Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®
Timothy A. Blizzard et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Penicillin-binding Protein 2a of Methicillin-resistant Staphylococcus aureus
Jennifer Fishovitz et al.
IUBMB LIFE (2014)
Siderophore Receptor-Mediated Uptake of Lactivicin Analogues in Gram-Negative Bacteria
Jeremy Starr et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe
Ann Versporten et al.
LANCET INFECTIOUS DISEASES (2014)
A variety of roles for versatile zinc in metallo-beta-lactamases
A. I. Karsisiotis et al.
METALLOMICS (2014)
Practical and Cost-Effective Manufacturing Route for the Synthesis of a β-Lactamase Inhibitor
Steven P. Miller et al.
ORGANIC LETTERS (2014)
Alkylidene Oxapenem β-Lactamase Inhibitors Revisited: Potent Broad Spectrum Activity but New Stability Challenges
Matthew D. Miller et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Enantioselective Synthesis and Profiling of Two Novel Diazabicyclooctanone β-Lactamase Inhibitors
Hui Xiong et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Structural Insight into Potent Broad-Spectrum Inhibition with Reversible Recyclization Mechanism: Avibactam in Complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-Lactamases
Sushmita D. Lahiri et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Ceftazidime-Avibactam: a Novel Cephalosporin/beta-lactamase Inhibitor Combination
George G. Zhanel et al.
DRUGS (2013)
β-Lactamase inhibitors: a review of the patent literature (2010-2013)
John D. Buynak
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Targeting metallo-β-lactamase enzymes in antibiotic resistance
Dustin T. King et al.
FUTURE MEDICINAL CHEMISTRY (2013)
Antibiotics in the clinical pipeline in 2013
Mark S. Butler et al.
JOURNAL OF ANTIBIOTICS (2013)
Activity of biapenem (RPX2003) combined with the boronate -lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial
Christopher Lucasti et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases
David E. Ehmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Design and Exploration of Novel Boronic Acid Inhibitors Reveals Important Interactions with a Clavulanic Acid-Resistant Sulfhydryl-Variable (SHV) β-Lactamase
Marisa L. Winkler et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Crystal Structures of KPC-2 β-Lactamase in Complex with 3-Nitrophenyl Boronic Acid and the Penam Sulfone PSR-3-226
Wei Ke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Activity of Ceftaroline-Avibactam Tested against Gram-Negative Organism Populations, including Strains Expressing One or More β-Lactamases and Methicillin-Resistant Staphylococcus aureus Carrying Various Staphylococcal Cassette Chromosome mec Types
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
In Vitro Activity of MK-7655, a Novel β-Lactamase Inhibitor, in Combination with Imipenem against Carbapenem-Resistant Gram-Negative Bacteria
Elizabeth B. Hirsch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The Importance of the trans-Enamine Intermediate as a ß-Lactamase Inhibition Strategy Probed in Inhibitor-Resistant SHV ß-Lactamase Variants
Wei Ke et al.
CHEMMEDCHEM (2012)
Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study
Jose A. Vazquez et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
Improving known classes of antibiotics: an optimistic approach for the future
Karen Bush
CURRENT OPINION IN PHARMACOLOGY (2012)
New Delhi Metallo-β-Lactamase: Structural Insights into β-Lactam Recognition and Inhibition
Dustin T. King et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Development of New Drugs for an Old Target - The Penicillin Binding Proteins
Astrid Zervosen et al.
MOLECULES (2012)
Prolonged Infusions of β-Lactam Antibiotics: Implication for Antimicrobial Stewardship
Jomy M. George et al.
PHARMACOTHERAPY (2012)
Fragment-guided design of subnanomolar β-lactamase inhibitors active in vivo
Oliv Eidam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor
David E. Ehmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-Producing Enterobacteriaceae
David M. Livermore et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Novel Insights into the Mode of Inhibition of Class A SHV-1 beta-Lactamases Revealed by Boronic Acid Transition State Inhibitors
Wei Ke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors
Yi Xia et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors
Ken Coleman
CURRENT OPINION IN MICROBIOLOGY (2011)
A Computational Evaluation of the Mechanism of Penicillin-Binding Protein-Catalyzed Cross-Linking of the Bacterial Cell Wall
Qicun Shi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Unexpected Tricovalent Binding Mode of Boronic Acids within the Active Site of a Penicillin-Binding Protein
Astrid Zervosen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Metallo-β-lactamases: a last frontier for β-lactams?
Giuseppe Cornaglia et al.
LANCET INFECTIOUS DISEASES (2011)
A Concise Synthesis of a β-Lactamase Inhibitor
Ian K. Mangion et al.
ORGANIC LETTERS (2011)
Updated Functional Classification of beta-Lactamases
Karen Bush et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Mechanistic Studies of the Inactivation of TEM-1 and P99 by NXL104, a Novel Non-β-Lactam β-Lactamase Inhibitor
Therese Stachyra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Structural study of phenyl boronic acid derivatives as AmpC beta-lactamase inhibitors
Donatella Tondi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
4,7-Dichloro benzothien-2-yl sulfonylaminomethyl boronic acid: First boronic acid-derived beta-lactamase inhibitor with class A, C, and D activity
Qiang Tan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents
Devdutt Chaturvedi et al.
CHEMICAL SOCIETY REVIEWS (2010)
Three Decades of beta-Lactamase Inhibitors
Sarah M. Drawz et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Alarming beta-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae
Karen Bush
CURRENT OPINION IN MICROBIOLOGY (2010)
Current Challenges in Antimicrobial Chemotherapy Focus on beta-Lactamase Inhibition
Carine Bebrone et al.
DRUGS (2010)
New beta-lactam antibiotics and beta-lactamase inhibitors
Karen Bush et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Activity of chequerboard combinations of ceftaroline and NXL104 versus β-lactamase-producing Enterobacteriaceae
S. Mushtaq et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Structural Basis for the Interaction of Lactivicins with Serine β-Lactamases
Tom Brown et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
Jose A. Caminero et al.
LANCET INFECTIOUS DISEASES (2010)
Structural and Biochemical Characterization of the Interaction between KPC-2 β-Lactamase and β-Lactamase Inhibitor Protein
Melinda S. Hanes et al.
BIOCHEMISTRY (2009)
Structure of PBP-A from Thermosynechococcus elongatus, a Penicillin-Binding Protein Closely Related to Class A β-Lactamases
Carole Urbach et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Why clinically used tazobactam and sulbactam are poor inhibitors of OXA-10 β-lactamase:: Raman crystallographic evidence
Monica A. Totir et al.
BIOCHEMISTRY (2008)
Structure of the covalent adduct formed between Mycobacterium tuberculosis β-lactamase and clavulanate
Lee W. Tremblay et al.
BIOCHEMISTRY (2008)
The Mechanisms of Catalysis by Metallo -Lactamases
Michael I. Page et al.
BIOINORGANIC CHEMISTRY AND APPLICATIONS (2008)
NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum β-lactamases and carbapenemases
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Penicillin-binding proteins and beta-lactam resistance
Andre Zapun et al.
FEMS MICROBIOLOGY REVIEWS (2008)
Optimizing cell permeation of an antibiotic resistance inhibitor for improved efficacy
Alberto Venturelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Cutting and stitching: The cross-linking of peptidoglycan in the assembly of the bacterial cell wall
John D. Buynak
ACS CHEMICAL BIOLOGY (2007)
4-substituted trinems as broad spectrum β-lactamase inhibitors:: Structure-based design, synthesis, and biological activity
Ivan Plantan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Carbapenemases:: the versatile β-lactamases
Anne Marie Queenan et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Reactivity and selectivity in the inhibition of elastase by 3-oxo-beta-sultams and in their hydrolysis
Wing-Yin Tsang et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2007)
Use of novel boronic acid transition state inhibitors to probe substrate affinity in SHV-type extended-spectrum beta-lactamases
Jodi M. Thomson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Structural and mechanistic basis of penicillin-binding protein inhibition by lactivicins
Pauline Macheboeuf et al.
NATURE CHEMICAL BIOLOGY (2007)
Structural analyses on intermediates in serine protease catalysis
Bin Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The deacylation mechanism of AmpC β-lactamase at ultrahigh resolution
Y Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Penicillin binding proteins: key players in bacterial cell cycle and drug resistance processes
Pauline Macheboeuf et al.
FEMS MICROBIOLOGY REVIEWS (2006)
Different transition-state structures for the reactions of β-lactams and analogous β-sultams with serine β-lactamases
WY Tsang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 β-lactamase
PS Padayatti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Crystal structures of complexes between the R61 DD-peptidase and peptidoglycan-mimetic β-lactams:: A non-covalent complex with a perfect penicillin
NR Silvaggi et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
The enzymology of clavam and carbapenem biosynthesis
NJ Kershaw et al.
CHEMICAL COMMUNICATIONS (2005)
Tazobactam forms a stoichiometric trans-enamine intermediate in the E166A variant of SHV-1 β-lactamase:: 1.63 Å crystal structure
PS Padayatti et al.
BIOCHEMISTRY (2004)
In vitro activity of AVE1330A, an innovative broad-spectrum non-β-lactam β-lactamase inhibitor
A Bonnefoy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
beta-lactams in the new millennium. Part-I: Monobactams and carbapenems
GS Singh
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2004)
β-sultams -: Mechanism of reactions and use as inhibitors of serine proteases
MI Page
ACCOUNTS OF CHEMICAL RESEARCH (2004)
Following the reactions of mechanism-based inhibitors with β-lactamase by Raman crystallography
MS Helfand et al.
BIOCHEMISTRY (2003)
Design and synthesis of pyrrolidine-5,5′-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease.: 4.: Antiviral activity and plasma stability
AD Borthwick et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Synthesis and biological activity of AM-112 and related oxapenem analogues
IN Simpson et al.
JOURNAL OF ANTIBIOTICS (2003)
Crystal structure of Enterobacter cloacae 908R class C β-lactamase bound to iodo-acetamido-phenyl boronic acid, a transition-state analogue
J Wouters et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2003)
In vitro and in vivo activities of AM-112, a novel oxapenem
CE Jamieson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
The importance of efflux pumps in bacterial antibiotic resistance
MA Webber et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Pyrrolidine-5,5-trans-lactams.: 1.: Synthesis and incorporation into inhibitors of hepatitis C virus NS3/4A protease
DM Andrews et al.
ORGANIC LETTERS (2002)
Resistance to β-lactam antibiotics:: Structure and mechanism based design of β-lactamase inhibitors
VP Sandanayaka et al.
CURRENT MEDICINAL CHEMISTRY (2002)
5,5-Fused thiophene gamma-lactams as templates for serine protease inhibition
ME Migaud et al.
CHEMICAL COMMUNICATIONS (2002)
Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxo-hexahydro-pyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease.: 1.: The α-methyl-trans-lactam template
AD Borthwick et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Hydrolytic stability versus ring size in lactams: Implications for the development of lactam antibiotics and other serine protease inhibitors
P Imming et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
